Tissue Regenix company

Tissue Regenix was founded in May 2006, to commercialise innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. The research has received in excess of £4 million grant funding to date from UK research councils (EPSRC, BBSRC) and the Children's Heart Surgery Fund.
Technology: Regenerative Medicine
Industry: Regenerative Medicine
Headquarters: York, York, United Kingdom
Founded Date: 6-28
Employees Number: 51-100
Funding Status: IPO
Investors Number: 3
Total Funding: £685K
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership